|
C1ORF156 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.6739999999803E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88808999999068E-05 |
| Normal-vs-Stage2 |
1.575890E-02 |
| Normal-vs-Stage3 |
4.876700E-03 |
| Normal-vs-Stage4 |
5.496300E-02 |
| Stage1-vs-Stage2 |
3.156800E-01 |
| Stage1-vs-Stage3 |
5.974600E-01 |
| Stage1-vs-Stage4 |
4.658600E-01 |
| Stage2-vs-Stage3 |
6.671200E-01 |
| Stage2-vs-Stage4 |
9.901000E-01 |
| Stage3-vs-Stage4 |
7.471600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.8616999999963E-06 |
| Normal-vs-AfricanAmerican |
2.104500E-03 |
| Normal-vs-Asian |
9.307800E-02 |
| Caucasian-vs-AfricanAmerican |
2.886400E-01 |
| Caucasian-vs-Asian |
6.697200E-01 |
| AfricanAmerican-vs-Asian |
9.674800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.64079999481959E-08 |
| Normal-vs-Female |
1.770130E-02 |
| Male-vs-Female |
8.944400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.926500E-02 |
| Normal-vs-Extreme_Weight |
4.29950000047086E-08 |
| Normal-vs-Obese |
5.382800E-04 |
| Normal-vs-Extreme_Obese |
1.486200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.909700E-02 |
| Normal_Weight-vs-Obese |
4.171000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.431600E-01 |
| Extreme_Weight-vs-Obese |
2.098800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.594800E-01 |
| Obese-vs-Extreme_Obese |
8.173400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.241800E-02 |
| Normal-vs-Age(41-60Yrs) |
7.773500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.45759999964557E-07 |
| Normal-vs-Age(81-100Yrs) |
3.576700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.009400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.962400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.105390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.325800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.130210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.962600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.14539999999053E-07 |
| Normal-VS-Type2 PRCC |
1.78113000000035E-05 |
| Normal-VS-KIRP CIMP |
5.982200E-02 |
| Normal-VS-Unclassified PRCC |
2.640300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.089600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.236400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.545400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.191600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.583400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.267800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.41990000002146E-06 |
| Normal-vs-N1 |
2.935200E-01 |
| Normal-vs-N2 |
1.599980E-02 |
| N0-vs-N1 |
2.048300E-02 |
| N0-vs-N2 |
6.208000E-01 |
| N1-vs-N2 |
1.735160E-01 |
|
|
